CA1111768A - Trans-broparestrol based therapeutic composition - Google Patents

Trans-broparestrol based therapeutic composition

Info

Publication number
CA1111768A
CA1111768A CA299,224A CA299224A CA1111768A CA 1111768 A CA1111768 A CA 1111768A CA 299224 A CA299224 A CA 299224A CA 1111768 A CA1111768 A CA 1111768A
Authority
CA
Canada
Prior art keywords
broparestrol
trans
composition
isomer
effects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA299,224A
Other languages
English (en)
French (fr)
Inventor
Marguerite S.L. Laroche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laroche Navarron SA
Original Assignee
Laroche Navarron SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laroche Navarron SA filed Critical Laroche Navarron SA
Application granted granted Critical
Publication of CA1111768A publication Critical patent/CA1111768A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/035—Halogenated hydrocarbons having aliphatic unsaturation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CA299,224A 1977-03-18 1978-03-17 Trans-broparestrol based therapeutic composition Expired CA1111768A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB11585/77 1977-03-18
GB11585/77A GB1561244A (en) 1977-03-18 1977-03-18 Broparestrol based therapeutic compositions

Publications (1)

Publication Number Publication Date
CA1111768A true CA1111768A (en) 1981-11-03

Family

ID=9988941

Family Applications (1)

Application Number Title Priority Date Filing Date
CA299,224A Expired CA1111768A (en) 1977-03-18 1978-03-17 Trans-broparestrol based therapeutic composition

Country Status (14)

Country Link
JP (1) JPS53121939A (de)
AU (1) AU515727B2 (de)
BE (1) BE864957A (de)
CA (1) CA1111768A (de)
CH (1) CH627076A5 (de)
DE (1) DE2811166A1 (de)
FR (1) FR2383665A1 (de)
GB (1) GB1561244A (de)
IE (1) IE46481B1 (de)
IL (1) IL54220A (de)
NL (1) NL7802938A (de)
NZ (1) NZ186722A (de)
PH (1) PH14956A (de)
ZA (1) ZA781539B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030764A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
ZW7487A1 (en) * 1986-05-23 1987-12-16 Hoffmann La Roche Tetrahydronaphthaline and indane derivatives
US5030765A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
AT388728B (de) * 1987-03-17 1989-08-25 Hoffmann La Roche Neue tetrahydronaphthalin- und indanderivate
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7459445B2 (en) 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds

Also Published As

Publication number Publication date
BE864957A (fr) 1978-09-18
GB1561244A (en) 1980-02-13
JPS53121939A (en) 1978-10-24
AU3427578A (en) 1979-09-20
CH627076A5 (en) 1981-12-31
NZ186722A (en) 1981-10-19
AU515727B2 (en) 1981-04-30
FR2383665A1 (fr) 1978-10-13
IL54220A0 (en) 1978-06-15
IL54220A (en) 1981-12-31
FR2383665B1 (de) 1980-10-24
PH14956A (en) 1982-02-05
DE2811166A1 (de) 1978-09-28
IE780497L (en) 1978-09-18
IE46481B1 (en) 1983-06-29
ZA781539B (en) 1979-03-28
NL7802938A (nl) 1978-09-20

Similar Documents

Publication Publication Date Title
EP0686037B1 (de) Hormon-ersatztherapie
AU691839B2 (en) Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women
US6500814B1 (en) Hormonal contraceptive
KR100365879B1 (ko) 프로게스테론길항제및게스타겐을포함하는자궁내막증식증또는자궁평활근종치료제
US5888543A (en) Oral contraceptives
EP0844884A2 (de) Endothelin-antagonisten und endothelin-synthase-inhibitoren zur prävention und behandlung von beschwerden im zusammenhang mit der uteruskontraktilität präeklampsie atherosklerotischen gefä erkrankungen hypertonie und zur hormonsubstitutionstherapie
DK165390B (da) Sekvenspraeparat til behandling af menopausale forstyrrelser
SK79596A3 (en) Means and method for hormonal contraception and/or the treatment of acne
DE60115274T2 (de) Verwendung von antiprogestinen zur prophylaxe und behandlung von hormonabhängigen erkrankungen
CA1111768A (en) Trans-broparestrol based therapeutic composition
KR20000029515A (ko) 프로게스틴과에스트로겐과의혼합물을포함하는단일상피임방법및키트
US4914089A (en) Pharmaceutical dosage unit
KR100501021B1 (ko) 경구 피임약
US20050064031A1 (en) Combination contraceptive, kits that contain the latter, and a method that uses the latter
EP1011681A1 (de) Orale kontrazeptive zubereitung enthaltend eine erste phase enthaltende eine kombination von gestagen/estrogen und eine zweite phase enthaltend gestagen
WO1994004156A1 (en) Antiprogestogen containing contraceptives
Keisler et al. Effects of prolonged administration of the 19-nor-testosterone derivatives norethindrone and norgestrel to female NZB/W mice: comparison with medroxyprogesterone and ethinyl estradiol
Popolow et al. Effects of perinatal androstenedione on sexual differentiation in female rats.
EP1605924B1 (de) Mesoprogestinen (progesteron-rezeptor-modulatoren) als bestandteil von zusammensetzungen für die hormonersatztherapie
WO1999009993A1 (en) Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
DE2712662A1 (de) Zubereitung fuer die behandlung von seborrhoea bei hunden
SE et al. European Patent Specification
Taché et al. Interruption of pregnancy in rats by various fluoroandrostane derivatives
WO1997041869A1 (en) Oral contraceptive

Legal Events

Date Code Title Description
MKEX Expiry